Investigation of Azole Resistance Involving
Aspergillus flavus
DNA mutation
antifungal susceptibility
azole resistance
cyp51A
cyp51B
mechanisms of resistance
Journal
Polish journal of microbiology
ISSN: 2544-4646
Titre abrégé: Pol J Microbiol
Pays: Poland
ID NLM: 101229003
Informations de publication
Date de publication:
03 May 2024
03 May 2024
Historique:
received:
03
08
2023
accepted:
03
12
2023
medline:
3
5
2024
pubmed:
3
5
2024
entrez:
3
5
2024
Statut:
aheadofprint
Résumé
This study aimed to investigate azole resistance mechanisms in
Identifiants
pubmed: 38700908
pii: pjm-2024-001
doi: 10.33073/pjm-2024-001
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 Dhoha Ghorbel et al., published by Sciendo.
Références
Alcazar-Fuoli L, Mellado E, Garcia-Effron G, Lopez JF, Grimalt JO, Cuenca-Estrella JM, Rodriguez-Tudela JL. Ergosterol biosynthesis pathway in Aspergillus fumigatus . Steroids. 2008 Mar;73(3):339–347. https://doi.org/10.1016/j.steroids.2007.11.005
doi: 10.1016/j.steroids.2007.11.005
Albarrag AM, Anderson MJ, Howard SJ, Robson GD, Warn PA, Sanglard D, Denning DW. Interrogation of related clinical panazole-resistant Aspergillus fumigatus strains: G138C, Y431C, and G434C single nucleotide polymorphisms in cyp51A , upregulation of cyp51A , and integration and activation of transposon Atf1 in the cyp51A promoter. Antimicrob Agents Chemother. 2011 Nov; 55(11):5113–5121. https://doi.org/10.1128/AAC.00517-11
doi: 10.1128/AAC.00517-11
Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res. 1997 Sep; 25(17):3389–3402. https://doi.org/10.1093/nar/25.17.3389
doi: 10.1093/nar/25.17.3389
Arikan-Akdagli S, Ghannoum M, Meis JF. Antifungal resistance: Specific focus on multidrug resistance in Candida auris and secondary azole resistance in Aspergillus fumigatus . J Fungi. 2018 Dec; 4(4):129. https://doi.org/10.3390/jof4040129
doi: 10.3390/jof4040129
Baranyi N, Kocsubé S, Jakšić Despot D, Šegvić Klarić M, Szekeres A, Bencsik O, Kecskeméti A, Manikandan P, et al. Combined genotyping strategy reveals structural differences between Aspergillus flavus lineages from different habitats impacting human health. J Basic Microbiol. 2017 Nov;57(11):899–909. https://doi.org/10.1002/jobm.201700243
doi: 10.1002/jobm.201700243
Biasini M, Bienert S, Waterhouse A, Arnold K, Studer G, Schmidt T, Kiefer F, Gallo Cassarino T, Bertoni M, Bordoli L, et al. SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res. 2014 Jul;42(W1):W252–W258. https://doi.org/10.1093/nar/gku340
doi: 10.1093/nar/gku340
Buil JB, Zoll J, Verweij PE, Melchers WJG. Molecular detection of azole-resistant Aspergillus fumigatus in clinical samples. Front Microbiol. 2018 Mar;9:515. https://doi.org/10.3389/fmicb.2018.00515
doi: 10.3389/fmicb.2018.00515
Camps SM, van der Linden JW, Li Y, Kuijper EJ, van Dissel JT, Verweij PE, Melchers WJ. Rapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: A case study and review of the literature. Antimicrob Agents Chemother. 2012 Jan;56(1):10–16. https://doi.org/10.1128/AAC.05088-11
doi: 10.1128/AAC.05088-11
Celia-Sanchez BN, Mangum B, Brewer M, Momany M. Analysis of Cyp51 protein sequences shows 4 major Cyp51 gene family groups across fungi. G3 Genes Genomes Genet. 2022 Nov;12(11):jkac249. https://doi.org/10.1093/g3journal/jkac249
doi: 10.1093/g3journal/jkac249
Chen J, Li H, Li R, Bu D, Wan Z. Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma. J Antimicrob Chemother. 2005 Jan;55(1):31–37. https://doi.org/10.1093/jac/dkh507
doi: 10.1093/jac/dkh507
Chowdhary A, Sharma C, Meis JF. Azole-resistant aspergillosis: Epidemiology, molecular mechanisms, and treatment. J Infect Dis. 2017 Aug;216(suppl_3):S436–S444. https://doi.org/10.1093/infdis/jix210
doi: 10.1093/infdis/jix210
Da Silva Ferreira ME, Colombo AL, Paulsen I, Ren Q, Wortman J, Huang J, Goldman MHS, Goldman GH. The ergosterol biosynthesis pathway, transporter genes, and azole resistance in Aspergillus fumigatus . Med Mycol. 2005 Jan;43(Suppl_1):S313–S319. https://doi.org/10.1080/13693780400029114
doi: 10.1080/13693780400029114
de Hoog GS, Nishikaku AS, Fernandez-Zeppenfeldt G, Padín-González C, Burger E, Badali H, Richard-Yegres N, van den Ende AH. Molecular analysis and pathogenicity of the Cladophialophora carrionii complex, with the description of a novel species. Stud Mycol. 2007;58:219–34. https://doi.org/10.3114/sim.2007.58.08
doi: 10.3114/sim.2007.58.08
Denning DW, Perlin DS. Azole resistance in Aspergillus : A growing public health menace. Future Microbiol. 2011 Nov;6(11):1229–32. https://doi.org/10.2217/fmb.11.118
doi: 10.2217/fmb.11.118
Espinel-Ingroff A, Turnidge J. The role of epidemiological cutoff values (ECVs/ECOFFs) in antifungal susceptibility testing and interpretation for uncommon yeasts and moulds. Rev Iberoam Micol. 2016 Apr-Jun;33(2):63–75. https://doi.org/10.1016/j.riam.2016.04.001
doi: 10.1016/j.riam.2016.04.001
Fattahi A, Zaini F, Kordbacheh P, Rezaie S, Safara M, Fateh R, Farahyar S, Kanani A, Heidari M. Evaluation of mRNA expression levels of cyp51A and mdr1 , candidate genes for voriconazole resistance in Aspergillus flavus . Jundishapur J Microbiol. 2015; 8(12): e26990. https://doi.org/10.5812/jjm.26990
doi: 10.5812/jjm.26990
Ferreira ME, Colombo AL, Paulsen I, Ren Q, Wortman J, Huang J, Goldman MH, Goldman GH. The ergosterol biosynthesis pathway, transporter genes, and azole resistance in Aspergillus fumigatus . Med Mycol. 2005 May;43(Suppl_1):S313–S319. https://doi.org/10.1080/13693780400029114
doi: 10.1080/13693780400029114
Fuhren J, Voskuil WS, Boel CH, Haas PJ, Hagen F, Meis JF, Kusters JG. High prevalence of azole resistance in Aspergillus fumigatus isolates from high-risk patients. J Antimicrob Chemother. 2015 Oct;70(10):2894–2898. https://doi.org/10.1093/jac/dkv177
doi: 10.1093/jac/dkv177
Furukawa T, van Rhijn N, Fraczek M, Gsaller F, Davies E, Carr P, Gago S, Fortune-Grant R, Rahman S, Gilsenan JM, et al. The negative cofactor 2 complex is a key regulator of drug resistance in Aspergillus fumigatus . Nat Commun. 2020 Jan;11(1):427. https://doi.org/10.1038/s41467-019-14191-1
doi: 10.1038/s41467-019-14191-1
Garcia-Effron G, Mellado E, Gomez-Lopez A, Alcazar-Fuoli L, Cuenca-Estrella M, Rodriguez-Tudela JL. Differences in interactions between azole drugs related to modifications in the 14-alpha sterol demethylase gene ( cyp51A ) of Aspergillus fumigatus . Antimicrob Agents Chemother. 2005 May;49(5):2119–2121. https://doi.org/10.1128/AAC.49.5.2119-2121.2005
doi: 10.1128/AAC.49.5.2119-2121.2005
Gonzalez-Jimenez I, Lucio J, Amich J, Cuesta I, Sanchez Arroyo R, Alcazar-Fuoli L, Mellado E. A Cyp51B mutation contributes to azole resistance in Aspergillus fumigatus . J Fungi. 2020 Nov;6(4):315. https://doi.org/10.3390/jof6040315
doi: 10.3390/jof6040315
Hadrich I, Makni F, Neji S, Abbes S, Cheikhrouhou F, Trabelsi H, Sellami H, Ayadi A. Invasive aspergillosis: Resistance to antifungal drugs. Mycopathologia. 2012a Aug;174(2):131–141. https://doi.org/10.1007/s11046-012-9526-y
doi: 10.1007/s11046-012-9526-y
Hadrich I, Makni F, Neji S, Cheikhrouhou F, Bellaaj H, Elloumi M, Ayadi A, Ranque S. Amphotericin B in vitro resistance is associated with fatal Aspergillus flavus infection. Med Mycol. 2012b Nov; 50(8):829–834. https://doi.org/10.3109/13693786.2012.684154
doi: 10.3109/13693786.2012.684154
Hadrich I, Makni F, Sellami H, Cheikhrouhou F, Sellami A, Bouaziz H, Hdiji S, Elloumi M, Ayadi A. Invasive aspergillosis: Epidemiology and environmental study in haematology patients (Sfax, Tunisia). Mycoses. 2010 Sep;53(5):443–447. https://doi.org/10.1111/j.1439-0507.2009.01710.x
doi: 10.1111/j.1439-0507.2009.01710.x
Hagiwara D, Watanabe A, Kamei K, Goldman GH. Epidemiological and genomic landscape of azole resistance mechanisms in Aspergillus Fungi. Front Microbiol. 2016 Sep;7:1382. https://doi.org/10.3389/fmicb.2016.01382
doi: 10.3389/fmicb.2016.01382
Hargrove TY, Friggeri L, Wawrzak Z, Qi A, Hoekstra WJ, Schotzinger RJ, York JD, Guengerich FP, Lepesheva GI. Structural analyses of Candida albicans sterol 14α-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis. J Biol Chem. 2017a Apr;292(16): 6728–6743. https://doi.org/10.1074/jbc.M117.778308
doi: 10.1074/jbc.M117.778308
Hargrove TY, Garvey EP, Hoekstra WJ, Yates CM, Wawrzak Z, Rachakonda G, Villalta F, Lepesheva GI. Crystal structure of the new investigational drug candidate VT-1598 in complex with Aspergillus fumigatus sterol 14α-demethylase provides insights into its broad-spectrum antifungal activity. Antimicrob Agents Chemother. 2017b Jun;61(7):e00570-17. https://doi.org/10.1128/AAC.00570-17
doi: 10.1128/AAC.00570-17
Hawkins NJ, Cools HJ, Sierotzki H, Shaw MW, Knogge W, Kelly SL, Kelly DE, Fraaije BA. Paralog re-emergence: A novel, historically contingent mechanism in the evolution of antimicrobial resistance. Mol Biol Evol. 2014 Jul;31(7):1793–1802. https://doi.org/10.1093/molbev/msu134
doi: 10.1093/molbev/msu134
Hedayati MT, Pasqualotto AC, Warn PA, Bowyer P, Denning DW. Aspergillus flavus : Human pathogen, allergen and mycotoxin producer. Microbiology. 2007 Jun;153(6):1677–1692. https://doi.org/10.1099/mic.0.2007/007641-0
doi: 10.1099/mic.0.2007/007641-0
Howard SJ, Arendrup MC. Acquired antifungal drug resistance in Aspergillus fumigatus : Epidemiology and detection. Med Mycol. 2011 Apr;49(Suppl_1):S90–S95. https://doi.org/10.3109/13693786.2010.508469
doi: 10.3109/13693786.2010.508469
Howard SJ, Cerar D, Anderson MJ, Albarrag A, Fisher MC, Pasqualotto AC, Laverdiere M, Arendrup MC, Perlin DS, Denning DW. Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure. Emerg Infect Dis. 2009 Jul;15(7):1068–1076. https://doi.org/10.3201/eid1507.090043
doi: 10.3201/eid1507.090043
Howard SJ, Pasqualotto AC, Denning DW. Azole resistance in allergic bronchopulmonary aspergillosis and Aspergillus bronchitis . Clin Microbiol Infect. 2010 Jun;16(6):683–688. https://doi.org/10.1111/j.1469-0691.2009.02911.x
doi: 10.1111/j.1469-0691.2009.02911.x
Koressaar T, Remm M. Enhancements and modifications of primer design program Primer3. Bioinformatics. 2007 May;23(10): 1289–1291. https://doi.org/10.1093/bioinformatics/btm091
doi: 10.1093/bioinformatics/btm091
Krishnan-Natesan S, Chandrasekar PH, Alangaden GJ, Manavathu EK. Molecular characterisation of cyp51A and cyp51B genes coding for P450 14alpha-lanosterol demethylases A (CYP51Ap) and B (CYP51Bp) from voriconazole-resistant laboratory isolates of Aspergillus flavus. Int J Antimicrob Agents. 2008 Dec; 32(6): 519–524. https://doi.org/10.1016/j.ijantimicag.2008.06.018
doi: 10.1016/j.ijantimicag.2008.06.018
Krishnan Natesan S, Wu W, Cutright JL, Chandrasekar PH. In vitro-in vivo correlation of voriconazole resistance due to G448S mutation ( cyp51A gene) in Aspergillus fumigatus . Diagn Microbiol Infect Dis. 2012 Nov;74(3):272–277. https://doi.org/10.1016/j.diagmicrobio.2012.06.030
doi: 10.1016/j.diagmicrobio.2012.06.030
Lescar J, Meyer I, Akshita K, Srinivasaraghavan K, Verma C, Palous M, Mazier D, Datry A, Fekkar A. Aspergillus fumigatus harbouring the sole Y121F mutation shows decreased susceptibility to voriconazole but maintained susceptibility to itraconazole and posaconazole. J Antimicrob Chemother. 2014 Dec;69(12):3244–3247. https://doi.org/10.1093/jac/dku316
doi: 10.1093/jac/dku316
Liu W, Sun Y, Chen W, Liu W, Wan Z, Bu D, Li R. The T788G mutation in the cyp51C gene confers voriconazole resistance in Aspergillus flavus causing aspergillosis. Antimicrob Agents Chemother. 2012 May;56(5):2598–603. https://doi.org/10.1128/AAC.05477-11
doi: 10.1128/AAC.05477-11
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 −ΔΔCT Method. Methods. 2001 Dec;25(4):402–408. https://doi.org/10.1006/meth.2001.1262
doi: 10.1006/meth.2001.1262
Lucio J, Gonzalez-Jimenez I, Rivero-Menendez O, Alastruey-Izquierdo A, Pelaez T, Alcazar-Fuoli L, Mellado E. Point mutations in the 14-α sterol demethylase Cyp51A or Cyp51C could contribute to azole resistance in Aspergillus flavus . Genes. 2020 Oct; 11(10):1217. https://doi.org/10.3390/genes11101217
doi: 10.3390/genes11101217
Mann PA, Parmegiani RM, Wei SQ, Mendrick CA, Li X, Loebenberg D, DiDomenico B, Hare RS, Walker SS, McNicholas PM. Mutations in Aspergillus fumigatus resulting in reduced susceptibility to posaconazole appear to be restricted to a single amino acid in the cytochrome P450 14alpha-demethylase. Antimicrob Agents Chemother. 2003 Feb;47(2):577–81. https://doi.org/10.1128/AAC.47.2.577-581.2003
doi: 10.1128/AAC.47.2.577-581.2003
Mashiach E, Schneidman-Duhovny D, Andrusier N, Nussinov R, Wolfson HJ. FireDock: A web server for fast interaction refinement in molecular docking. Nucleic Acids Res. 2008 Jul;36(suppl_2): W229–W232. https://doi.org/10.1093/nar/gkn186
doi: 10.1093/nar/gkn186
Meena DS, Kumar D, Bohra GK, Kumar G. Clinical manifestations, diagnosis, and treatment outcome of CNS aspergillosis: A systematic review of 235 cases. Infect Dis Now. 2021 Nov;51(8): 654–660. https://doi.org/10.1016/j.idnow.2021.04.002
doi: 10.1016/j.idnow.2021.04.002
Mellado E, Alcazar-Fuoli L, Cuenca-Estrella M, Rodriguez-Tudela JL. Role of Aspergillus lentulus 14-α sterol demethylase (Cyp51A) in azole drug susceptibility. Antimicrob Agents Chemother. 2011 Dec;55(12):5459–5468. https://doi.org/10.1128/AAC.05178-11
doi: 10.1128/AAC.05178-11
Mellado E, Diaz-Guerra TM, Cuenca-Estrella M, Rodriguez-Tudela JL. Identification of two different 14-alpha sterol demethylase-related genes ( cyp51A and cyp51B ) in Aspergillus fumigatus and other Aspergillus species. J Clin Microbiol. 2001 Jul;39(7):2431–2438. https://doi.org/10.1128/JCM.39.7.2431-2438.2001
doi: 10.1128/JCM.39.7.2431-2438.2001
Mellado E, Garcia-Effron G, Alcazar-Fuoli L, Cuenca-Estrella M, Rodriguez-Tudela JL. Substitutions at methionine 220 in the 14alpha-sterol demethylase (Cyp51A) of Aspergillus fumigatus are responsible for resistance in vitro to azole antifungal drugs. Antimicrob Agents Chemother. 2004 Jul;48(7):2747–2750. https://doi.org/10.1128/AAC.48.7.2747-2750.2004
doi: 10.1128/AAC.48.7.2747-2750.2004
Monk BC, Tomasiak TM, Keniya MV, Huschmann FU, Tyndall JD, O’Connell JD 3rd, Cannon RD, McDonald JG, Rodriguez A, Finer-Moore JS, et al. Architecture of a single membrane spanning cytochrome P450 suggests constraints that orient the catalytic domain relative to a bilayer. Proc Natl Acad Sci USA. 2014 Mar;111(10):3865–3870. https://doi.org/10.1073/pnas.1324245111
doi: 10.1073/pnas.1324245111
Nascimento AM, Goldman GH, Park S, Marras SA, Delmas G, Oza U, Lolans K, Dudley MN, Mann PA, Perlin DS. Multiple resistance mechanisms among Aspergillus fumigatus mutants with high-level resistance to itraconazole. Antimicrob Agents Chemother. 2003 May;47(5):1719–1726. https://doi.org/10.1128/AAC.47.5.1719-1726.2003
doi: 10.1128/AAC.47.5.1719-1726.2003
Nierman WC, Pain A, Anderson MJ, Wortman JR, Kim HS, Arroyo J, Berriman M, Abe K, Archer DB, Bermejo C, et al. Genomic sequence of the pathogenic and allergenic filamentous fungus Aspergillus fumigatus . Nature. 2005 Dec;438(7071):1151–6. https://doi.org/10.1038/nature04332
doi: 10.1038/nature04332
Patterson TF, Thompson GR 3rd, Denning DW, Fishman JA, Hadley S, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Nguyen MH, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2016 Aug;63(4):e1–e60. https://doi.org/10.1093/cid/ciw326
doi: 10.1093/cid/ciw326
Paul RA, Rudramurthy SM, Meis JF, Mouton JW, Chakrabarti A. A novel Y319H substitution in CYP51C associated with azole resistance in Aspergillus flavus . Antimicrob Agents Chemother. 2015 Oct; 59(10):6615–6619. https://doi.org/10.1128/AAC.00637-15
doi: 10.1128/AAC.00637-15
Rhodes J, Abdolrasouli A, Dunne K, Sewell TR, Zhang Y, Ballard E, Brackin AP, van Rhijn N, Chown H, Tsitsopoulou A, et al. Population genomics confirms acquisition of drug-resistant Aspergillus fumigatus infection by humans from the environment. Nat Microbiol. 2022 May;7(5):663–674. https://doi.org/10.1038/s41564-022-01091-2
doi: 10.1038/s41564-022-01091-2
Sagatova AA, Keniya MV, Wilson RK, Monk BC, Tyndall JD. Structural insights into binding of the antifungal drug fluconazole to Saccharomyces cerevisiae lanosterol 14α-demethylase. Antimicrob Agents Chemother. 2015 Aug;59(8):4982–9. https://doi.org/10.1128/AAC.00925-15
doi: 10.1128/AAC.00925-15
Sharma C, Kumar R, Kumar N, Masih A, Gupta D, Chowdhary A. Investigation of multiple resistance mechanisms in voriconazole-resistant Aspergillus flavus clinical isolates from a chest hospital surveillance in Delhi, India. Antimicrob Agents Chemother. 2018 Feb;62(3):e01928–17. https://doi.org/10.1128/AAC.01928-17
doi: 10.1128/AAC.01928-17
Shelton JMG, Rhodes J, Uzzell CB, Hemmings S, Brackin AP, Sewell TR, Alghamdi A, Dyer PS, Fraser M, Borman AM, et al. Citizen science reveals landscape-scale exposures to multiazoleresistant Aspergillus fumigatus bioaerosols. Sci Adv. 2023 Jul;9(29): eadh8839. https://doi.org/10.1126/sciadv.adh8839
doi: 10.1126/sciadv.adh8839
Sievers F, Wilm A, Dineen D, Gibson TJ, Karplus K, Li W, Lopez R, McWilliam H, Remmert M, Söding J, et al. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol. 2011 Oct;7:539. https://doi.org/10.1038/msb.2011.75
doi: 10.1038/msb.2011.75
Snelders E, van der Lee HA, Kuijpers J, Rijs AJ, Varga J, Samson RA, Mellado E, Donders AR, Melchers WJ, Verweij PE. Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism. PLoS Med. 2008 Nov;5(11):e219. https://doi.org/10.1371/journal.pmed.0050219
doi: 10.1371/journal.pmed.0050219
Stothard P. The sequence manipulation suite: JavaScript programs for analyzing and formatting protein and DNA sequences. Biotechniques. 2000 Jun;28(6):1102–1104. https://doi.org/10.2144/00286ir01
doi: 10.2144/00286ir01
Thenmozhi M, Kannabiran K. Interaction of Streptomyces sp. VITSTK7 compounds with selected antifungal drug target enzymes by in silico molecular docking studies. Interdiscip Sci. 2013 Jun;5(2): 145–149. https://doi.org/10.1007/s12539-013-0163-z
doi: 10.1007/s12539-013-0163-z
Untergasser A, Cutcutache I, Koressaar T, Ye J, Faircloth BC, Remm M, Rozen SG. Primer3 – new capabilities and interfaces. Nucleic Acids Res. 2012 Aug;40(15):e115. https://doi.org/10.1093/nar/gks596
doi: 10.1093/nar/gks596
Van Rhijn N, Bromley M, Richardson M, Bowyer P. CYP51 paralogue structure is associated with intrinsic azole resistance in fungi. mBio. 2021 Oct 26;12(5):e0194521. https://doi.org/10.1128/mBio.01945-21
doi: 10.1128/mBio.01945-21
VanGuilder HD, Vrana KE, Freeman WM. Twenty-five years of quantitative PCR for gene expression analysis. Biotechniques. 2008 Apr;44(5):619–626. https://doi.org/10.2144/000112776
doi: 10.2144/000112776
Vermeulen E, Lagrou K, Verweij PE. Azole resistance in Aspergillus fumigatus : A growing public health concern. Curr Opin Infect Dis. 2013 Dec;26(6):493–500. https://doi.org/10.1097/QCO.0000000000000005
doi: 10.1097/QCO.0000000000000005
Verweij PE, Chowdhary A, Melchers WJ, Meis JF. Azole resistance in Aspergillus fumigatus : Can we retain the clinical use of moldactive antifungal azoles? Clin Infect Dis. 2016 Feb;62(3):362–368. https://doi.org/10.1093/cid/civ885
doi: 10.1093/cid/civ885